Our results also showed that CSF NfL levels were correlated with age, EDSS scores, the number of relapses, and the number of T2 lesions in patients with MS, which is in agreement with the findings of previous studies [24-26]. The gene discussed is NEFL; the disease is myeloid sarcoma.